Election 2014
SENSEX NIFTY

Drugs

Apr 16, 2014 at 09:16 | Source: Moneycontrol.com
Glenmark Generic Inc, USA a subsidiary of Glenmark Generic Limited, has been granted final abbreviated new drug approval (ANDA) from USFDA for Eszopiclone Tablets. Glenmark will commence distribution of the product immediately.
Apr 15, 2014 at 17:51 | Source: CNBC-TV18
The pharma company had licensed out the drug, GBR 500, to Sanofi and had received an upfront payment of USD 50 million dollars from the French drugmaker in 2012.
Apr 15, 2014 at 16:40 | Source: Reuters
The confidence in India marks a shift from last year when IT outsourcing firms and drug makers featured among top gainers as investors sought more exposure to the global economy, with economic growth at its weakest pace in a decade.
Apr 15, 2014 at 14:16 | Source: Reuters
The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year because of discoloration.
Apr 09, 2014 at 19:20 | Source: Reuters
Uday Baldota, Sun Pharma's senior vice president of finance and accounts, didn't comment directly when asked whether Sun Pharma will phase out Ranbaxy-branded products in the United States. "Overall Ranbaxy brand has a value," he said. "We will find ways of using it and preserving it."
Apr 09, 2014 at 16:40 | Source: PTI
Lupin said its US subsidiary, Lupin Pharmaceuticals Inc has received final approval for its Pioglitazone tablets from the US Food and Drugs Administration to market generic version of Takeda Pharmaceuticals USA Inc's Actos tablets.
Apr 09, 2014 at 14:20 | Source: Moneycontrol.com
Lupin announced today that it has received final approval for its Pioglitazone Tablets USP, 15 mg, 30 mg, and 45 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Takeda Pharmaceuticals USA, Inc.s (Takeda) Actos Tablets, 15 mg, 30 mg, and 45 mg.
Apr 09, 2014 at 09:53 | Source: Moneycontrol.com
Neuland Laboratories opened a new manufacturing facility constructed as part of its collaboration with Tokyo-based API Corporation (APIC), a healthcare unit of Mitsubishi Chemical Holdings Group that produces APIs, intermediates and investigational new drugs, along with fine chemicals and reagents.
Apr 07, 2014 at 11:21 | Source: Reuters
Daiichi Sankyo said Ranbaxy shareholders will get 0.8 Sun Pharma shares for each Ranbaxy share. The merged company will also become the largest drug firm in India.
Apr 07, 2014 at 09:15 | Source: Moneycontrol.com
Both Sun Pharmaceutical Industries and Ranbaxy are in focus on the back of the acquisition. Sun Pharma will acquire Ranbaxy Laboratories, which has been facing quality issues for its drugs in the US market, in an all-stock transaction with a total value of USD 4 billion.
Messages on Drugs »

fzaidi

Silver Member

1 Followers

Aanjaneya Life  

Dr Datsons Labs in talks with strategic investors for stake sale BY ANURADHA VERMA Market rumours suggest Videocon Group is looking to hike its stake in the pharma company. Mid-sized drug maker Dr Datsons Labs is negotiating with various pharma companies and other strategic investors

11.45 PM Apr 16th

nimbagal

Platinum Member

29 Followers

Sun Pharma  

Yep, After the deal, Sun Pharma is india`s largest drug maker with a market share of around 9 per cent and worlds 5th largest. Tardes at 615 levels. Hold and sit tight..

8.57 PM Apr 16th

HH@320

Gold Member

4 Followers

Natco Pharma  

But the chances of decision before May are very less so a little delay in permission is sure, here it should be noted that Natco is expecting 25% revenue gain from such drug...

7.13 PM Apr 16th

HH@320

Gold Member

4 Followers

Natco Pharma  

Actually the problem is from USA, TEVA`s appeal over capaxon, lets see what happen ahead, if judgement is in favor of TEVA then Natco will be allowed to sell the said drug from Sept. 2015 and if decision is in favor of natco, they will be allowed to sell the same from May, 2014

7.11 PM Apr 16th

Web Messenger

Platinum Member

208339 Followers

Cadila Health  

Source:Calcutta Telegraph News - New Delhi, April 15 (PTI): Cadila Healthcare and Zydus Pharmaceuticals today said they had entered into a settlement agreement with Depomed Inc in a patent infringement row. The case is related to Depomed’s neuropathic pain relieving drug Gralise. Cadila Healthcare

3.31 PM Apr 16th

BSE/NSE Announcer

Platinum Member

2315 Followers

Venmax Drugs  

Venmax Drugs and Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on March 31, 2014.

12.25 PM Apr 16th

Market Statistician

Platinum Member

7980 Followers

Beryl Drugs  

At 12:09 hrs, Beryl Drugs was trading at Rs 34.20 down 0.73%. During the last one hour the stock declined 5.61%. See more

12.15 PM Apr 16th

Expert Chartist

Platinum Member

9101 Followers

Godavari Drugs  

At 10:30 hrs Godavari Drugs has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Apr 16th

Expert Chartist

Platinum Member

9101 Followers

Parabolic Drugs  

At 10:40 hrs Parabolic Drugs has formed a gap down chart pattern today. A Gap Down forms when the high for a day is lower than the previous days low. More technicals.

11.00 AM Apr 16th

Expert Chartist

Platinum Member

9101 Followers

Combat Drugs  

At 10:12 hrs Combat Drugs has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Apr 16th

News across the web »
Apr 17, 2014 at 05:45 | Source: FirstPost
Apr 17, 2014 at 05:06 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.